Sie verwenden eine veraltete Version Ihres Internetbrowsers und können nicht auf die Inhalte der Seite zugreifen.
Bitte aktualisieren Sie Ihre Browserversion.
Van Heeswijk, R.; Boogaerts, G.; De Paepe, E.; Van Solingen-Ristea, R.; Garg, V.; Beumont, M., The pharmacokinetic interaction between escitalopram and the investigational HCV protease inhibitor telaprevir [abstract 12]. 5th International Workshop on Clinical Pharmacology of Hepatitis Therapy; Boston, MA. June 23–24, 2010. [7397]
Van Heeswijk, R.; Boogaerts, G.; De Paepe, E.; Van Solingen-Ristea, R.; Garg, V.; Beumont, M., The pharmacokinetic interaction between escitalopram and the investigational HCV protease inhibitor telaprevir [abstract 12]. 5th International Workshop on Clinical Pharmacology of Hepatitis Therapy; Boston, MA. June 23–24, 2010. [7398]
Van Heeswijk, R.; Boogaerts, G.; De Paepe, E.; Van Solingen-Ristea, R.; Garg, V.; Beumont, M., The pharmacokinetic interaction between escitalopram and the investigational HCV protease inhibitor telaprevir [abstract 12]. 5th International Workshop on Clinical Pharmacology of Hepatitis Therapy; Boston, MA. June 23–24, 2010. [7399]
van Helvoort M. Int Clin Psychopharmacol. Sep 2019; 34(5): 269-272 Pubmed[9131]
van Hoppe S. Pharmacol Res. Aug 2019; 146: 104297 Pubmed[11487]
van Hoppe S. Pharmacol Res. Jun 2017; 120: 43-50 Pubmed[7756]
Van Kammen DP. Psychopharmacologia. Nov 1975; 44(3): 215-24 Pubmed[1743]
van Kan HJ. Biopharm Drug Dispos. Apr 2008; 29(3): 139-44 Pubmed[11375]
van Laar MW. Psychopharmacology (Berl). Aug 2002; 162(4): 351-63 Pubmed[11246]
van Leeuwen DJ. Ned Tijdschr Geneeskd. Mar 1986; 130(12): 548-50 Pubmed[6091]
Van LM. J Psychopharmacol. Nov 2006; 20(6): 834-41 Pubmed[13738]
van Luin M. AIDS. May 2010; 24(8): 1223-6 Pubmed[6421]
van Luin M. J Acquir Immune Defic Syndr. Sep 2010; 55(1): 82-6 Pubmed[7378]
van Luin M. J Clin Pharmacol. Oct 2009; 49(10): 1220-7 Pubmed[2953]
van Maarseveen EM. AIDS Patient Care STDS. Oct 2012; 26(10): 568-81 Pubmed[8981]
van Meerten E. Drug Saf. Mar 1995; 12(3): 168-82 Pubmed[7341]
van Nuland M. Prostate Cancer Prostatic Dis. Jun 2020; 23(2): 244-251 Pubmed[12403]
van Praag HM. Biol Psychiatry. Feb 1987; 22(2): 205-12 Pubmed[8281]
Van Rooij J. Br J Clin Pharmacol. Jun 1993; 35(6): 661-3 Pubmed, Volltext, DOI[8584]
van Seyen M. Clin Pharmacol Ther. Nov 2019; 106(5): 1093-1098 Pubmed[8058]
Van Slooten AD. DICP. Jun 1991; 25(6): 578-82 Pubmed[5833]
Van Strater AC. Int Clin Psychopharmacol. Mar 2012; 27(2): 121-4 Pubmed[1129]